首页> 美国卫生研究院文献>The Journal of International Medical Research >Increased risk of atrial fibrillation among patients undergoing coronary artery bypass graft surgery while receiving nitrates and antiplatelet agents
【2h】

Increased risk of atrial fibrillation among patients undergoing coronary artery bypass graft surgery while receiving nitrates and antiplatelet agents

机译:接受硝酸盐和抗血小板药物同时接受冠状动脉搭桥手术的患者发生房颤的风险增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPostoperative atrial fibrillation (POAF) is a frequent complication of coronary artery bypass graft (CABG) surgery. This arrhythmia occurs more frequently among patients who receive perioperative inotropic therapy (PINOT). Administration of nitrates with antiplatelet agents reduces the conversion rate of cyclic guanosine monophosphate to guanosine monophosphate. This process is associated with increased concentrations of free radicals, catecholamines, and blood plasma volume. We hypothesized that patients undergoing CABG surgery who receive PINOT may be more susceptible to POAF when nitrates are administered with antiplatelet agents.
机译:背景术后房颤(POAF)是冠状动脉搭桥术(CABG)的常见并发症。这种心律不齐在围手术期正性肌力疗法(PINOT)的患者中更常见。用抗血小板药给予硝酸盐可降低环状鸟苷单磷酸转化为鸟苷单磷酸的转化率。该过程与自由基,儿茶酚胺的浓度增加和血浆体积增加有关。我们假设接受抗血小板药物硝酸盐治疗的接受PINOT的CABG手术患者可能更容易发生POAF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号